Bio-Works Technologies AB (publ)

NGM:BIOWKS 株式レポート

時価総額:SEK 65.5m

Bio-Works Technologies 過去の業績

過去 基準チェック /06

Bio-Works Technologiesの収益は年間平均-4.9%の割合で減少していますが、 Medical Equipment業界の収益は年間 増加しています。収益は年間22.9% 24.9%割合で 増加しています。

主要情報

-4.9%

収益成長率

2.3%

EPS成長率

Medical Equipment 業界の成長6.2%
収益成長率24.9%
株主資本利益率-65.1%
ネット・マージン-99.0%
次回の業績アップデート21 Feb 2025

最近の業績更新

Recent updates

Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

Dec 25
Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

Aug 30
Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth

We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

Feb 21
We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

Oct 25
We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth

We Think Bio-Works Technologies (STO:BIOWKS) Can Easily Afford To Drive Business Growth

May 10
We Think Bio-Works Technologies (STO:BIOWKS) Can Easily Afford To Drive Business Growth

Bio-Works Technologies (STO:BIOWKS) Is In A Strong Position To Grow Its Business

Sep 27
Bio-Works Technologies (STO:BIOWKS) Is In A Strong Position To Grow Its Business

Is Bio-Works Technologies (STO:BIOWKS) In A Good Position To Invest In Growth?

May 11
Is Bio-Works Technologies (STO:BIOWKS) In A Good Position To Invest In Growth?

Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Have Been Selling

Mar 20
Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Have Been Selling

How Much Are Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Taking Off The Table?

Dec 05
How Much Are Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Taking Off The Table?

収支内訳

Bio-Works Technologies の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NGM:BIOWKS 収益、費用、利益 ( )SEK Millions
日付収益収益G+A経費研究開発費
30 Sep 2438-38650
30 Jun 2435-47740
31 Mar 2439-52780
31 Dec 2344-57820
30 Sep 2340-54810
30 Jun 2345-50810
31 Mar 2343-48780
31 Dec 2241-45750
30 Sep 2238-45720
30 Jun 2234-45700
31 Mar 2245-29660
31 Dec 2156-13630
30 Sep 2150-14580
30 Jun 2144-15540
31 Mar 2125-29510
31 Dec 207-45490
30 Sep 207-42490
30 Jun 207-42490
31 Mar 207-45510
31 Dec 196-42460
30 Sep 196-55530
30 Jun 195-51490
31 Mar 195-41390
31 Dec 187-38370
30 Sep 186-25270
30 Jun 186-22260
31 Mar 187-26300
31 Dec 176-24290
30 Sep 176-20250
31 Dec 166-17240
31 Dec 153-12170

質の高い収益: BIOWKSは現在利益が出ていません。

利益率の向上: BIOWKSは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: BIOWKSは利益が出ておらず、過去 5 年間で損失は年間4.9%の割合で増加しています。

成長の加速: BIOWKSの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: BIOWKSは利益が出ていないため、過去 1 年間の収益成長をMedical Equipment業界 ( 31% ) と比較することは困難です。


株主資本利益率

高いROE: BIOWKSは現在利益が出ていないため、自己資本利益率 ( -65.1% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘